CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published ahead of print on November 23, 2005
Clinical Journal of the American Society of Nephrology
© 2005 American Society of Nephrology
doi: 10.2215/CJN.00010505
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
CJN.00010505v1
1/1/70    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, D. Y.
Right arrow Articles by Kalantar-Zadeh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, D. Y.
Right arrow Articles by Kalantar-Zadeh, K.

Received May 21, 2005
Accepted on October 20, 2005

Original Articles

Association between Serum Bicarbonate and Death in Hemodialysis Patients: Is It Better to Be Acidotic or Alkalotic?

Dennis Y. Wu *, Christian S. Shinaberger *{dagger}, Deborah L. Regidor *{dagger}, Charles J. McAllister {ddagger}, Joel D. Kopple *, and Kamyar Kalantar-Zadeh *1

*Division of Nephrology and Hypertension, Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance, California; {dagger}School of Public Health, University of California, Los Angeles, Los Angeles, California; and {ddagger}DaVita, Inc., El Segundo, California


1 To whom correspondence should be addressed. E-mail: kamkal{at}ucla.edu.


   Abstract

The optimal acid-base status for survival in maintenance hemodialysis (MHD) patients remains controversial. According to recent reports, acidosis is associated with improved survival in MHD patients. It was hypothesized that this inverse association is due to a confounding effect of the malnutrition-inflammation complex syndrome (MICS). Associations between baseline (first 3 mo averaged) predialysis serum bicarbonate (HCO3-) and 2-yr mortality were examined in 56,385 MHD patients who were treated in virtually all DaVita dialysis clinics across the United States. The range of HCO3- was divided into 12 categories (<17, ≥27, and 10 groups in between). Three sets of Cox regression models were evaluated to estimate hazard ratios of all-cause and cardiovascular death in both incident and prevalent patients: (1) Unadjusted, (2) multivariate case mix adjusted (which also included dialysate HCO3- and Kt/V), and (3) adjusted for case mix and nine markers of MICS (body mass index; erythropoietin dose; protein intake; serum albumin; creatinine; phosphorus; calcium; ferritin and total iron binding capacity; and blood hemoglobin, WBC, and lymphocytes). There were significant inverse associations between serum HCO3- and serum phosphorus and estimated protein intake. The lowest unadjusted mortality was associated with predialysis HCO3- in the 17- to 23-mEq/L range, whereas values ≥23 mEq/L were associated with progressively higher all-cause and cardiovascular death rates. This association, however, reversed after case-mix and MICS multivariate adjustment, so that HCO3- values >22 mEq/L had lower death risk. Although previous epidemiologic studies indicated an association between high serum HCO3- and increased mortality in MHD patients, this effect seems to be due substantially to the effect of MICS on survival.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C. P. Kovesdy, J. E. Anderson, and K. Kalantar-Zadeh
Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD
Nephrol. Dial. Transplant., November 17, 2008; (2008) gfn633v1.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. S. Shinaberger, J. D. Kopple, C. P. Kovesdy, C. J. McAllister, D. van Wyck, S. Greenland, and K. Kalantar-Zadeh
Ratio of Paricalcitol Dosage to Serum Parathyroid Hormone Level and Survival in Maintenance Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1769 - 1776.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. P. Kovesdy, D. L. Regidor, R. Mehrotra, J. Jing, C. J. McAllister, S. Greenland, J. D. Kopple, and K. Kalantar-Zadeh
Serum and Dialysate Potassium Concentrations and Survival in Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 999 - 1007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Society of Nephrology.